SDH-deficient gastrointestinal stromal tumors: paradoxical effect of imatinib
Succinate dehydrogenase deficient gastrointestinal stromal tumors (dSDH GIST) is a unique group of GISTs with an energy metabolism defect as the key oncogenic mechanism without mutations in the proto-oncogene receptor tyrosine kinase (KIT) and platelet-derived growth factor receptor a (PDGFRA). SDH-...
Guardado en:
Autores principales: | Daria A. Filonenko, Andrey A. Meshcheryakov, Petr P. Arkhiri, Maxim P. Nikulin, Evgeniia S. Kolobanova |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Habib O.N.
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/553e488d924d466a9a73765baf3532ec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tumores estromales gastrointestinales duodenales: Report of one case
por: Carvajal H,Carlos, et al.
Publicado: (2006) -
Gastrointestinal Stromal Tumors (GISTs): Single Center Experience Observed in a Small Series of Cases
por: Manterola,Carlos, et al.
Publicado: (2016) -
Successful Treatment of Imatinib-Induced DRESS Syndrome Using Reslizumab without Cessation of Imatinib: A Case Report
por: Hyerin Park, et al.
Publicado: (2021) -
Avapritinib: a new tyrosine kinase inhibitor for treatment of advanced gastrointestinal stromal tumors. The literature review and clinical case
por: Daria A. Filonenko, et al.
Publicado: (2021) -
Clinicopathological features, clinical efficacy on 101 cases of rectal gastrointestinal stromal tumors, and the significance of neoadjuvant therapy
por: Hongxin Yang, et al.
Publicado: (2021)